Pro-oxidative and pro-apoptotic pathways

The term **pro-oxidative and pro-apoptotic pathways** describes interconnected cellular signaling processes that promote elevated reactive oxygen species production (pro-oxidation) and trigger apoptosis, the programmed cell death.[2][3][9] The intrinsic apoptotic pathway is usually mediated by mitochondrial damage and oxidative stress, regulating the expression of numerous *pro-apoptotic* (e.g., Bax, Bak, Bid) and *anti-apoptotic* proteins (e.g., Bcl-2, Bcl-xL)[3][4][9]. Upon mitochondrial membrane disruption, molecules like cytochrome c are released, forming the apoptosome and activating caspases that execute apoptosis[1][3][4][5][9]. The extrinsic pathway involves ligands binding death receptors and activating caspase-8. Oxidative stress and apoptosis are central to tissue homeostasis, cancer suppression, and response to injury or toxic agents. While the term is widely used to describe therapeutic strategies (e.g., chemotherapeutics that induce ROS and apoptosis in cancer cells[2][6]), it is not a single protein, receptor, enzyme, or molecular therapeutic target, but rather a general description of a cellular process that incorporates multiple proteins, enzymes, and signaling cascades.

Other names

Pro-oxidant pathwaysPro-apoptotic pathways

Induction of reactive oxygen species (ROS); Activation of caspase cascade (via intrinsic/extrinsic apoptosis); Disruption of mitochondrial membrane integrity; Activation/deactivation of pro- and anti-apoptotic protein families (e.g., Bcl-2, Bax, Bak, p53)